Biotech- Leader Since 2011 Lows, Faces Key Resistance Test
November 02, 2015 at 11:10 AM EST
Today we look at Biotech ETF (IBB), as its has been in the leadership role since the 2011 lows. IBB fell harder during the summer softness and rallied over the past month along with the broad markets.
